Medicamen Biotech Share Price
Know More₹563.10 1.00 (0.18%)
04:00 PM, 13-Dec-2024₹565.90-5.65 (-0.99%)
03:51 PM, 13-Dec-2024BSE : 531146
NSE : MEDICAMEQ
Sector : Health care
ISIN Code : INE646B01010
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 13-Dec-2024 | 04:00 PM IST
| Market Cap (₹ Cr) | 716 |
Traded Value (₹ Cr) | 0.11 |
Volume (Shares) | 1,948 |
Face Value (₹) | 10 |
52-Week High (₹) | 630.00 |
52-Week High Date | 06-Dec-2024 |
52-Week Low (₹) | 356.75 |
52-Week Low Date | 13-Mar-2024 |
All Time High (₹) | 1,219.00 |
All Time High Date | 01-Sep-2022 |
All Time Low (₹) | 2.25 |
All Time Low Date | 18-Apr-2001 |
Medicamen Biotech Ltd
Market News
Medicamen Biotec Announcement
Medicamen Biotech Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 719 |
| EPS - TTM (₹) [C] | 5.77 |
| P/E Ratio (X) [C] | 98.08 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 19-Sep-2024 |
| Dividend Yield (%) | 0.18 |
| Book Value Share (₹) [C] | 169.82 |
| P/B Ratio (₹) [C] | 3.33 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 76 | 0.02 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 561.00 594.00 |
| Week Low/High (₹) | 560.00 630.00 |
| Month Low/High (₹) | 430.00 630.00 |
| Year Low/High (₹) | 355.45 630.00 |
| All time Low/High (₹) | 2.25 1,225.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -6.72% | -6.39% | 0.52 | 0.37% |
| 1 Month | 23.92% | 25.21% | 5.72 | 5.13% |
| 3 Month | 20.98% | 20.60% | -0.91 | -2.32% |
| 6 Month | 18.80% | 19.00% | 6.93 | 5.85% |
| 1 Year | -2.70% | -2.86% | 18.03 | 18.36% |
| 3 Year | -29.85% | -29.64% | 40.92 | 42.61% |
Company Info
Company Information
Non Executive Director : Sanjay Bansal
Chairman (Non-Executive) : Rahul Bishnoi
Non Executive Director : Ashwani Kumar Sharma
Independent Director : Harish Pande
Non Executive Director : S K Singh
Independent Director : Arun Kumar
Company Sec. & Compli. Officer : Parul Choudhary
Independent Director : Sumita Dwivedi
Non Executive Director : Vimal Kumar Shrawat.
Independent Director : Sangeeta Bishnoi
Independent Director : Ravi Kumar Bansal
Registered Office: 1506 Chiranjiv Tower 43, Nehru Place,New Delhi,New Delhi-110019 Ph: 91-11-47589500
Email:cs@medicamen.com
FAQs about Medicamen Biotech Ltd
1. What's the Medicamen Biotech Ltd share price today?
Medicamen Biotech Ltd share price was Rs 563.10 at 04:00 PM IST on 13th Dec 2024. Medicamen Biotech Ltd share price was up by 0.18% over the previous closing price of Rs 562.10. Medicamen Biotech Ltd share price trend:
- Last 1 Month: Medicamen Biotech Ltd share price moved up by 23.92% on BSE
- Last 3 Months: Medicamen Biotech Ltd share price moved up by 20.98% on BSE
- Last 12 Months: Medicamen Biotech Ltd share price moved down by 2.70% on BSE
- Last 3 Years: Medicamen Biotech Ltd price moved down by 29.85% on BSE
2. How can I quickly analyse the performance of the Medicamen Biotech Ltd stock?
The performance of the Medicamen Biotech Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 98.08
- Price to book value ratio is 3.33
- Dividend yield of 0.18
- The EPS (trailing 12 months) of the Medicamen Biotech Ltd stock is Rs 5.77
3. What is the market cap of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a market capitalisation of Rs 716 crore.
4. What is Medicamen Biotech Ltd's 52-week high/low share price?
The Medicamen Biotech Ltd’s 52-week high share price is Rs 630.00 and 52-week low share price is Rs 356.75.
5. Is the Medicamen Biotech Ltd profitable?
On a consolidated basis, Medicamen Biotech Ltd reported a profit of Rs 2.27 crore on a total income of Rs 43.13 crore for the quarter ended 2024. For the year ended Sep 2024, Medicamen Biotech Ltd had posted a profit of Rs 0.90 crore on a total income of Rs 45.03 crore.
6. Which are Medicamen Biotech Ltd’s peers in the Health care sector?
Medicamen Biotech Ltd’s top 5 peers in the Health care sector are Nectar Lifesci., Kwality Pharma, Albert David, Medicamen Biotec, Ind-Swift Labs., Titan Biotech, Jenburkt Pharma.
7. Who owns how much in Medicamen Biotech Ltd?
Key changes to the Medicamen Biotech Ltd shareholding are as follows:
- Promoter holding in Medicamen Biotech Ltd has gone down to 42.99 per cent as of Sep 2024 from 43.21 per cent as of Dec 2023.
